DHR Health

Edinburg, Texas 78539

1 studies enrolling now · 5 studies all time

What they study most

COVID-19, Covid19, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Metastatic Pancreas Adenocarcinoma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenosquamous Carcinoma, Pancreatic Cancer, Pancreatic Cancer Metastatic

Studies at this site

• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients — Running, not enrolling
• Afrezza® INHALE-1 Study in Pediatrics — Completed
• Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting — Status unconfirmed
• B2RAD Translational Medicine Study — Status unconfirmed